非血缘造血干细胞移植——儿童重型再生障碍性贫血的一线治疗选择?
被引量:1
Matched Unrelated Donor Hematopoietic Stem Cell Transplantation——First-Line Therapy for Children with Severe Aplastic Anemia?
摘要
造血干细胞移植是治疗儿童重型再生障碍性贫血(SAA)的重要措施,HLA相合的同胞供体(MSD)移植是公认的儿童SAA一线治疗方法。随着移植技术的快速发展,非血缘相关供体(MUD)移植疗效有了大幅度提高,许多中心达到了与MSD一样的治疗效果,因此HLA高分辨相合MUD有望成为儿童SAA的首选治疗。
出处
《实用儿科临床杂志》
CAS
CSCD
北大核心
2012年第15期1144-1146,共3页
Journal of Applied Clinical Pediatrics
参考文献39
-
1Thomas ED, Storb R, Fefer A, et al. Aplastic anemia treated by bone marrow transplantation [ J]. Lancet, 1972,1:284 - 289.
-
2Mathe G, Amiel JL, Schwarzenberg L, et al. Bone marrow graft in man after conditioning by antilymphocytic serum [ J ]. Transplant Proc, 1971, 3(1) :325 -332.
-
3Kobayashi R, Yabe H, Hara J, et al. Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the inci- dence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA - identical siblings [J]. Br I Haematol.2006.135(5) ,693 -696.
-
4Locasciulli A, Oneto R, Bacigalupo A, et al. Severe aplastic anemia working party of the European blood and marrow transplant group. Out- come of patients with acquired aplastic anemia given first line bone mar- row transplantation or immunosuppressive treatment in the last decade : A report from the European Group for Blood and Marrow Transplantation (EBMT) [ J ]. Haematologica,2007,92 ( 1 ) : 11 - 18.
-
5Stucki A, Leisenring W, Sandmaier BM, et al. Decreased rejection and improved survival of first and second marrow transplants for severe aplas- tie anemia( a 26 - year retrospective analysis) [ J ]. Blood, 1998,92 (8) : 2742 - 2749.
-
6Young NS, Calado RT, Scheinberg P. Current concepts in the patho- physiology and treatment of aplastic anemia [ J ]. Blood,2006, 108 (8) : 2509 - 2519.
-
7Scheinberg P, Wu CO, Nunez O, et al. Long - term outcome of pediat- ric patients with severe aplastic anemia treated with antithymocyte globu- lin and cyclosporine[ J ]. J Pediatr,2008,153 (6) :814 - 819.
-
8FUhrer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children:A more severe disease predicts better survi- val[J]. Blood,2005,106(6) :2102 -2104.
-
9Bagby GC, Meyers G. Bone marrow failure as a risk factor for clonal e- volution : Prospects for leukemia prevention [ J ]. Hematol Am Soc Hema- tol Educ Program ,2007:40 - 46.
-
10罗成娟,陈静,薛惠良,汤静燕,潘慈,江华,董璐,罗长缨,叶启东,周敏,顾龙君.125例儿童再生障碍性贫血患者疗效分析[J].中华血液学杂志,2010,31(8):531-535. 被引量:18
二级参考文献25
-
1Kobayashi R,Yabe H,Hara J,et al.Preceding immunosuppressive therapy with antithymocyte globulin and cyclosporine increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLAidentical siblings.Br J Haematol,2006,135:693-696.
-
2Locasciulli A,Oneto R,Bacigalupo A,et al.Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade:a report from the European Group for Blood and Marrow Transplantation (EBMT).Haematologica,2007,92:11-18.
-
3Young NS,Calado RT,Scheinberg P.Current concepts in the pathophysiology and treatment of aplastic anemia.Blood,2006,108:2509-2519.
-
4ScheinbergP,WuCO,NunezO,et al.Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.J Pediatr,2008,153:814-819.
-
5Fuhrer M,Rampf U,Banmann I,et al.Immunosuppressive therapy for aplastic anemia in children:a more severe disease predicts better survival.Blood,2005,106:2102-2104.
-
6Marsh J,Schrezenmeier H,Marin P,et al.Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia:a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.Blood,1999,93:2191-2195.
-
7Bacigalupo A,Hows J,Gordon-Smith EC,et al.Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings:A report of the BMT Working Party.Bone Marrow Transplant,1988,3:531-535.
-
8Margolis D,Camitta B,Pietryga D,et al.Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults.Br J Haematol,1996,94:65-72.
-
9Kosaka Y,Yagasaki H,Sano K,et al.Prospective multicenter trial comparing repeated immunosuppressive therapy with stem cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia.Blood,2008,111:1054-1059.
-
10Eapen M,Ramsay NK,Mertens AC,et al.Late outcomes after bone marrow transplant for aplastic anaemia.Br J Haematol,2000,111:754-760.
共引文献23
-
1贾苍松.小儿血液系统疾病临床研究进展[J].中国实用儿科杂志,2008,23(5):345-347. 被引量:1
-
2李昌崇,张维溪.儿童呼吸系统疾病研究进展[J].中国实用儿科杂志,2010,25(5):351-353. 被引量:2
-
3刘义红,熊丽萍,张海燕.儿童再生障碍性贫血的诊断及治疗中存在问题[J].临床和实验医学杂志,2010,9(21):1655-1657.
-
4王天有.儿童血液系统疾病临床研究进展[J].中国实用儿科杂志,2011,26(5):352-355.
-
5赵晓莉,杜莉,潘凯丽.抗胸腺细胞球蛋白治疗儿童再生障碍性贫血8例疗效分析[J].中国当代儿科杂志,2011,13(9):760-762. 被引量:1
-
6朱兴善,朴玉善.小儿应用环孢素软胶囊引起不良反应1例[J].中国当代医药,2011,18(30):134-135.
-
7刘希民,黄宁,周芳.异基因造血干细胞移植治疗重型再生障碍性贫血Ⅱ型患者临床分析[J].中华移植杂志(电子版),2011,5(2):27-30. 被引量:2
-
8朱晓华,高怡瑾,陆凤娟,翟晓文,王宏胜,李军,苗慧,钱晓文.免疫抑制治疗儿童再生障碍性贫血疗效分析[J].临床儿科杂志,2012,30(5):428-430. 被引量:8
-
9乔淑敏,王易,胡绍燕.异基因造血干细胞移植治疗儿童重型再生障碍性贫血[J].实用儿科临床杂志,2012,27(15):1167-1169. 被引量:6
-
10苏淑芳,吕艳琦,李白,刘玉峰.急性重型再生障碍性贫血72例[J].实用儿科临床杂志,2012,27(15):1185-1186. 被引量:8
-
1杨晓春,陈诗庭,严海林,郑绍同.儿童重型再生障碍性贫血预后分析:附23例报告[J].临床儿科杂志,2001,19(1):39-40.
-
2陈兴杰,李素兰,贾新萍.甲基强的松龙冲击治疗儿童重型再生障碍性贫血3例护理[J].河南医科大学学报,2000,35(2):185-185.
-
3季海娟,戴江,孙国俊.沙美特罗替卡松治疗儿童中度哮喘的临床疗效观察[J].儿科药学杂志,2008,14(2):48-49. 被引量:1
-
4李琚海.吸入用布地奈德混悬液配合孟鲁司特钠治疗支气管哮喘的效果分析[J].今日健康,2015,14(10):47-47. 被引量:1
-
5殷新华.鼻塞式CPAP治疗早期新生儿肺透明膜病探讨[J].中外医疗,2014,33(33):21-22.
-
6谢晓恬,王耀平,刘振荣,石苇,刘兴元.联合免疫抑制治疗儿童重型再生障碍性贫血[J].中华血液学杂志,1998,19(4):214-215. 被引量:3
-
7造血器官及血液疾病[J].中国中西医结合儿科学,1999(5):302-303.
-
8唐湘凤,栾佐,吴南海,徐世侠,王凯,龚小军.非血缘脐带造血干细胞移植治疗慢性肉芽肿1例[J].实用儿科临床杂志,2010,25(15):1143-1143. 被引量:1
-
9刘敬.小儿消化道出血43例临床分析[J].中华临床医学杂志,2005,6(5):66-66.
-
10田广德,季海娟,康裕斌.普米克和博利康尼雾化吸入联合氢化可的松治疗毛细支气管炎疗效观察[J].现代医药卫生,2008,24(2):215-215.